424-18287-87751
3 vaccinations
2 coded responses
3 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 928 / CA
- Registered
- 2021-12-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Pfizer-BioNTech
-
2021-03-25
Dose 2 — Pfizer-BioNTech
-
2021-12-15
Registered in v-safe
-
2021-12-15
Dose 3 — Pfizer-BioNTech
-
2021-12-18
Survey response — days 1–6 daily, dose 3MedDRA: Neck pain — Feeling: Fair · Site: PainFree text: Pain at base of neckMedDRA releases: 2024-11 · check-in free text available
-
2022-06-17
Survey response — 6 months, dose 3MedDRA: Cough, Nasal congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Stuffy nose and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-12-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Pfizer-BioNTech | No |
| 2 | 2021-03-25 | Pfizer-BioNTech | No |
| 3 | 2021-12-15 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Pain at base of neck
Release 12 — 6 months, dose 3
Symptoms: Stuffy nose and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SRO | Neck pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release